(0.38%) 5 119.42 points
(0.29%) 38 350 points
(0.39%) 15 990 points
(-0.62%) $83.33
(2.86%) $1.978
(0.01%) $2 347.50
(-0.10%) $27.51
(3.13%) $950.95
(-0.04%) $0.934
(-0.03%) $11.02
(-0.30%) $0.798
(1.45%) $93.20
Live Chart Being Loaded With Signals
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software...
Stats | |
---|---|
本日の出来高 | 63.00 |
平均出来高 | 999.00 |
時価総額 | 99.24B |
EPS | €0.682 ( 2023-10-31 ) |
Last Dividend | €0.690 ( 2023-09-21 ) |
Next Dividend | €0 ( N/A ) |
P/E | 25.51 |
ATR14 | €0.138 (0.18%) |
Medtronic PLC 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Medtronic PLC 財務諸表
Annual | 2022 |
収益: | €31.23B |
総利益: | €20.51B (65.67 %) |
EPS: | €2.83 |
FY | 2022 |
収益: | €31.23B |
総利益: | €20.51B (65.67 %) |
EPS: | €2.83 |
FY | 2022 |
収益: | €31.69B |
総利益: | €21.54B (67.98 %) |
EPS: | €3.75 |
FY | 2021 |
収益: | €30.12B |
総利益: | €19.63B (65.19 %) |
EPS: | €2.69 |
Financial Reports:
No articles found.
Medtronic PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0.680 (N/A) |
€0.680 (N/A) |
€0.680 (N/A) |
€0.690 (N/A) |
€0.690 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.320 | 2008-03-26 |
Last Dividend | €0.690 | 2023-09-21 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 58 | -- |
Total Paid Out | €24.44 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.01 | -- |
Div. Sustainability Score | 9.19 | |
Div.Growth Potential Score | 3.67 | |
Div. Directional Score | 6.43 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
HLE.DE | Ex Dividend Knight | 2023-05-02 | Annually | 0 | 0.00% | |
SBS.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
CCC3.DE | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
KLA.DE | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% | |
TR9.F | No Dividend Player | 2023-07-21 | Annually | 0 | 0.00% | |
DTG.DE | Ex Dividend Junior | 2023-06-22 | Insufficient data to determine frequency | 0 | 0.00% | |
MUV2.DE | Ex Dividend Junior | 2023-05-08 | Annually | 0 | 0.00% | |
7HP.DE | Ex Dividend Knight | 2023-09-12 | Quarterly | 0 | 0.00% | |
WSU.DE | Ex Dividend Junior | 2023-05-16 | Annually | 0 | 0.00% | |
FNTN.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.130 | 1.500 | 7.40 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0462 | 1.200 | 8.46 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0816 | 1.500 | -0.204 | -0.307 | [0.1 - 1] |
payoutRatioTTM | 0.871 | -1.000 | 1.293 | -1.293 | [0 - 1] |
currentRatioTTM | 2.30 | 0.800 | 3.51 | 2.80 | [1 - 3] |
quickRatioTTM | 1.459 | 0.800 | 6.12 | 4.90 | [0.8 - 2.5] |
cashRatioTTM | 0.166 | 1.500 | -0.190 | -0.286 | [0.2 - 2] |
debtRatioTTM | 0.277 | -1.500 | 5.38 | -8.07 | [0 - 0.6] |
interestCoverageTTM | 8.05 | 1.000 | 8.13 | 8.13 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.15 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.486 | -1.500 | 8.06 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.655 | 1.000 | 2.42 | 2.42 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.175 | 1.000 | 8.50 | 8.50 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.257 | 1.000 | 9.68 | 9.68 | [0.2 - 2] |
assetTurnoverTTM | 0.356 | 0.800 | -0.961 | -0.769 | [0.5 - 2] |
Total Score | 9.19 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.16 | 1.000 | 7.56 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0816 | 2.50 | -0.131 | -0.307 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.71 | 2.00 | 8.76 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.47 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.87 | 2.00 | 8.38 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.871 | 1.500 | 1.293 | -1.293 | [0 - 1] |
pegRatioTTM | -0.956 | 1.500 | -9.71 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.200 | 1.000 | 7.50 | 0 | [0.1 - 0.5] |
Total Score | 3.67 |
Medtronic PLC
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。